… for RAI ablation success in intermediate-to-high-risk DTC patients. … risk factors might require
high-dose of 131 I as RAI ablation in accordance with the ATA guideline while RAI ablation …

… Therefore, we assessed the predictive accuracy of the microRNA-based risk score in DTC
… than the ATA risk score. Compared to indolent tumors, a higher risk score was found in …

… RAI ablation therapy in patients with DTC using propensity score … Thus, RAI ablation remains
controversial in ATA low-risk … RAI ablation in DTC patients according to recurrence risk [8]. …

… for these low risk DTCs. The aim of this study was to validate a new dynamic risk stratification
(… in patients with DTC treated without radioactive iodine (RAI) remnant ablation therapy. …

… Our study based on large-sample data indicated that RAI ablation only benefits
intermediate-risk PTC patients with male gender, age ≥ 45 years and tumor size > 20 mm. …

… In conclusion, the present study identifies the risk factors of recurrence after total
thyroidectomy plus neck dissection and RAI ablation therapy in ATA high-risk PTC patients. …

… iodine (RAI) ablation have shifted away from virtually all cases of papillary thyroid cancer
(PTC) to selected cases of more advanced disease in patients who are at higher risk for … -score …

… iodine (RAI) ablation in low-risk (LR) and intermediate-risk (IR) patients is controversial. The
aim of this study was to evaluate whether RAI ablation … -analysis showed RAI ablation in LR-…

Background The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy
in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate …

… ablation consists of the destruction of the remnant thyroid tissue with the administration of
radioactive iodine; it … Examples of three possible score in evaluation of remnant ablation 1 year …